CHBOF (China Health Technology Group Holding Co) Piotroski F-Score: 7 (As of Jun. 26, 2026) — 40% Above Median


CHBOF China Health Technology Group Holding Co Ltd CHBOF
25 GF Score
Price $0.03
GF Value $0.07
! 7 Warning Signs
View Full Analysis

What is China Health Technology Group Holding Co Piotroski F-Score?

China Health Technology Group Holding Co CHBOF 25 Piotroski F-Score is 7 as of Jun. 26, 2026, which is 40% above its 10-year median of 5.00. GuruFocus rates CHBOF with a GF Score™ of 25/100 and a GF Value™ of $0.07. The stock has 7 warning signs investors should review. Among 282 Forest Products companies, China Health Technology Group Holding Co ranks better than 93.97% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

China Health Technology Group Holding Co has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for China Health Technology Group Holding Co's Piotroski F-Score or its related term are showing as below:

CHBOF' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 7
Current: 7

During the past 13 years, the highest Piotroski F-Score of China Health Technology Group Holding Co was 7. The lowest was 3. And the median was 5.

China Health Technology Group Holding Co  (OTCPK:CHBOF) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


China Health Technology Group Holding Co Piotroski F-Score Related Terms


China Health Technology Group Holding Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for China Health Technology Group Holding Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Health Technology Group Holding Co Piotroski F-Score Chart

China Health Technology Group Holding Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Jun22 Jun23 Jun24 Jun25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 5.00 7.00 4.00 7.00

China Health Technology Group Holding Co Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 4.00 0.00 7.00 0.00

CHBOF vs SSD, UFPI, BCC: Piotroski F-Score Comparison

For the Lumber & Wood Production subindustry, China Health Technology Group Holding Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Health Technology Group Holding Co Piotroski F-Score vs Forest Products Industry

For the Forest Products industry and Basic Materials sector, China Health Technology Group Holding Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where China Health Technology Group Holding Co's Piotroski F-Score falls into.


CHBOF
25GF Score
China Health Technology Group Holding Co Ltd CHBOF
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun25) TTM:Last Year (Jun24) TTM:
Net Income was $3.16 Mil.
Cash Flow from Operations was $4.83 Mil.
Revenue was $12.56 Mil.
Gross Profit was $1.14 Mil.
Average Total Assets from the begining of this year (Jun24)
to the end of this year (Jun25) was (24.559 + 28.608) / 2 = $26.5835 Mil.
Total Assets at the begining of this year (Jun24) was $24.56 Mil.
Long-Term Debt & Capital Lease Obligation was $16.10 Mil.
Total Current Assets was $8.36 Mil.
Total Current Liabilities was $6.00 Mil.
Net Income was $27.57 Mil.

Revenue was $6.56 Mil.
Gross Profit was $0.26 Mil.
Average Total Assets from the begining of last year (Jun23)
to the end of last year (Jun24) was (19.639 + 24.559) / 2 = $22.099 Mil.
Total Assets at the begining of last year (Jun23) was $19.64 Mil.
Long-Term Debt & Capital Lease Obligation was $15.97 Mil.
Total Current Assets was $6.52 Mil.
Total Current Liabilities was $6.80 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

China Health Technology Group Holding Co's current Net Income (TTM) was 3.16. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

China Health Technology Group Holding Co's current Cash Flow from Operations (TTM) was 4.83. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun24)
=3.163/24.559
=0.12879189

ROA (Last Year)=Net Income/Total Assets (Jun23)
=27.57/19.639
=1.4038393

China Health Technology Group Holding Co's return on assets of this year was 0.12879189. China Health Technology Group Holding Co's return on assets of last year was 1.4038393. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

China Health Technology Group Holding Co's current Net Income (TTM) was 3.16. China Health Technology Group Holding Co's current Cash Flow from Operations (TTM) was 4.83. ==> 4.83 > 3.16 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun24 to Jun25
=16.103/26.5835
=0.60575169

Gearing (Last Year: Jun24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun23 to Jun24
=15.974/22.099
=0.72283814

China Health Technology Group Holding Co's gearing of this year was 0.60575169. China Health Technology Group Holding Co's gearing of last year was 0.72283814. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun25)=Total Current Assets/Total Current Liabilities
=8.362/5.999
=1.39389898

Current Ratio (Last Year: Jun24)=Total Current Assets/Total Current Liabilities
=6.523/6.798
=0.95954693

China Health Technology Group Holding Co's current ratio of this year was 1.39389898. China Health Technology Group Holding Co's current ratio of last year was 0.95954693. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

China Health Technology Group Holding Co's number of shares in issue this year was 97.565. China Health Technology Group Holding Co's number of shares in issue last year was 79.349. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1.144/12.564
=0.0910538

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0.261/6.562
=0.03977446

China Health Technology Group Holding Co's gross margin of this year was 0.0910538. China Health Technology Group Holding Co's gross margin of last year was 0.03977446. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun24)
=12.564/24.559
=0.51158435

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun23)
=6.562/19.639
=0.33413107

China Health Technology Group Holding Co's asset turnover of this year was 0.51158435. China Health Technology Group Holding Co's asset turnover of last year was 0.33413107. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+0+1+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

China Health Technology Group Holding Co has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
China Health Technology Group Holding Co (CHBOF) has a Piotroski F-Score of 7 as of Jun. 26, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on China Health Technology Group Holding Co and its competitors. This is 40% above median its historical median of 5.00. Over the past decade, China Health Technology Group Holding Co's Piotroski F-Score has ranged from 3.00 to 7.00. According to the industry distribution chart, China Health Technology Group Holding Co ranks #17 out of 282 companies in the Forest Products industry, placing it in the top 6%.
Is China Health Technology Group Holding Co's Piotroski F-Score too high?
China Health Technology Group Holding Co's current Piotroski F-Score of 7 is 40% above median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 7.00. The Forest Products industry median Piotroski F-Score is 5.00. China Health Technology Group Holding Co's value of 7 is 40% above this industry median. Based on the distribution chart, China Health Technology Group Holding Co ranks #17 out of 282 companies in the Forest Products industry, which is in the top quartile — a strong position relative to peers. Overall, China Health Technology Group Holding Co has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does China Health Technology Group Holding Co's Piotroski F-Score compare to SSD and UFPI?
According to the Forest Products industry distribution chart, China Health Technology Group Holding Co ranks #17 out of 282 companies for Piotroski F-Score. This places China Health Technology Group Holding Co in the top 6% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. China Health Technology Group Holding Co's value of 7 is 40% above this benchmark. Historically, China Health Technology Group Holding Co's own Piotroski F-Score has ranged from 3.00 to 7.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, China Health Technology Group Holding Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Forest Products company?
The median Piotroski F-Score among Forest Products companies is 5.00, based on 282 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Health Technology Group Holding Co's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on China Health Technology Group Holding Co and its competitors. For the Forest Products industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Health Technology Group Holding Co's current Piotroski F-Score is 7, which is 40% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Technology Group Holding Co stock overvalued right now?
China Health Technology Group Holding Co (CHBOF) has a current Piotroski F-Score of 7. The stock's GF Value™ is $0.07, compared to a current price of $0.03 — trading 52.9% below its estimated fair value. The current Piotroski F-Score is 7, which is 40% above median its 10-year median of 5.00 and 40% above the Forest Products industry median of 5.00. China Health Technology Group Holding Co's overall GF Score™ is 25/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For China Health Technology Group Holding Co (CHBOF), the current Piotroski F-Score is 7 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Health Technology Group Holding Co (CHBOF) Overvalued in 2026?

Based on GuruFocus' analysis, China Health Technology Group Holding Co stock appears to be undervalued. The current stock price of $0.03 is trading 52.9% below its estimated GF Value™ of $0.07.

Key valuation signals for CHBOF:

  • Piotroski F-Score: 7 (40% above median its 10-year median of 5.00)
  • GF Value™: $0.07 vs. price of $0.03 (52.9% below fair value)
  • GF Score™: 25/100 with 7 warning signs
  • Industry Position: 40% above the Forest Products median (#17 of 282)

No single metric tells the full story. See the CHBOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Health Technology Group Holding Co Business Description

Other Exchanges 01069:Hong Kong
Address South Binhe Avenue, Room 4903, Building A, West Tower, C Future City, Futian District, Shenzhen, CHN
China Health Technology Group Holding Co Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has reportable segments including the Forestry business; Horny Goat Weed Business; Health products business and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Forestry business segment. Geographically company generates its key revenue from the PRC.
25GF Score

Get the complete analysis for CHBOF

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.03
Price
$0.07
GF Value